Bioequivalence of Alprazolam Sublingual vs Oral Tablets
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study tests the assumption that the bioavailability of alprazolam from a new sublingual
formulation is the same as that from a standard orally administered tablet.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.